Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial

The CORTICO-COP trial showed that eosinophil-guided corticosteroid-sparing treatment for acute exacerbation of chronic obstructive pulmonary disease was non-inferior to standard of care and decreased the accumulated dose of systemic corticosteroids that patients were exposed to by approximately 60%....

Descripción completa

Detalles Bibliográficos
Autores principales: Sivapalan, Pradeesh, Bikov, Andras, Suppli Ulrik, Charlotte, Lapperre, Therese Sophie, Mathioudakis, Alexander G., Højberg Lassen, Mats Christian, Grundtvig Skaarup, Kristoffer, Biering-Sørensen, Tor, Vestbo, Jørgen, Jensen, Jens-Ulrik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234000/
https://www.ncbi.nlm.nih.gov/pubmed/34205765
http://dx.doi.org/10.3390/jcm10122734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234000/
https://www.ncbi.nlm.nih.gov/pubmed/34205765
http://dx.doi.org/10.3390/jcm10122734

Ejemplares similares